News New cancer treatment approved in Australia (19 Dec 18) Novartis Australia has announced the TGA approval of Kymriah® (tisagenlecleucel), for the…Cell TherapiesDecember 19, 2018
News Dr Dawn Driscoll appointed as CEO at Cell Therapies Pty Ltd Cell Therapies Pty Ltd is delighted to announce the appointment of Dr Dawn Driscoll as…Cell TherapiesOctober 4, 2017
News CTPL awarded Australian Global Innovation Linkages programme grant Melbourne, Australia 26 June 2017: Cell Therapies has been awarded $1,000,000 in funding by the…Cell TherapiesJune 26, 2017
News CTPL receives APAC Bioprocessing Excellence Award Melbourne, Australia 20 February 2017: Cell Therapies commitment to, and excellence in, bringing innovative cellular…Cell TherapiesFebruary 20, 2017
News CTPL CEO, Tim Oldham, elected to Alliance for Regenerative Medicine 2017 Board of Directors Melbourne, Australia, 11 October 2016: Cell Therapies Pty Ltd (CTPL) is pleased to announce that…Cell TherapiesOctober 26, 2016
News ISCT 2016 CT's contribution to ISCT 2016 Representatives from Cell Therapies presented at ISCT Singapore on the…Cell TherapiesAugust 19, 2016
News Apheresis for cellular therapy manufacturing: need for improved collection data Melbourne 8 Feb 2016: Cell collection via apheresis is the starting point for manufacture of…Cell TherapiesFebruary 8, 2016
News Reform Needed To Fulfill Our Biotech Potential REFORM NEEDED TO FULFILL OUR BIOTECH POTENTIAL is an article by AusBiotech’s Chief Executive, Dr…Cell TherapiesOctober 7, 2015
News Confirmation of BioNexus Award to CTPL Melbourne and Kuala Lumpur 30 Sep 2015: Cell Therapies Pty Ltd (CTPL) has today received…Cell TherapiesOctober 5, 2015
News CTPL CSO Dominic Wall comments on opportunities and challenges of CAR-T therapy in lead-up to AusBiotech 2015 Cell Therapies’ Chief Scientific Officer, Dr Dominic Wall will participate in AusBiotech2015 as part of…Cell TherapiesSeptember 25, 2015